Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions

Urology

Volumn 48, Issue 6 SUPPL., 1996, Pages 33-39

  Woodrum, David ^a   French, Chet ^a   Shamel, L Blair ^a  

^a Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD STORAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS;

EID: 0030456911     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00607-3     Document Type: Article

References (28)

1. Wang MC, Valenzuela LA, Murphy GP, and Chu TM: Purification of human prostate specific antigen. Invest Urol 17: 159-163, 1979.
2. Papsidero LD, Kuriyama M, Wang MC, Horoszewicz JS, Leong SS, Valenzuela L, Murphy GP, and Chu TM: Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 66: 37-42, 1981.
3. Qiu S-D, Young CY, Bilhartz DL, Prescott JL, Farrow GM, He WW, and Tindall DJ: In situ hybridization of prostate-specific antigen mRNA in human prostate. J Urol 144: 1550-1556, 1990.
4. Lundwall A: Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun 161: 1151-1159, 1989.
5. Christensson A, Laurell CB, and Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194: 755-763, 1990.
6. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, and Alfthan O: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
7. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang T, Wolfert R, Lilja H, Oesterling J: Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45: 729-744, 1995.
8. Catalona WJ, Ritchie J, Ahmann FK, Hudson M, Scardino P, Flanigan R, DeKernion J, Ratliff T, Kavoussi L, Dalkin B, Waters B, MacFarlane M, and Southwick P: Comparision of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
9. Catalona WJ, Smith DS, Ratliff TL, and Rasler JW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954, 1993.
10. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen MT, Cockett ATK, Abrahamsson PA, and Lilja H: Serum prostate specific antigen complexed to alpha 1 antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105, 1993.
11. Catalona WJ, Smith DS, Wolfert R, Wang TJ, Rittenhouse H, Ratliff TL, and Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274: 1214-1220, 1995.
12. Schifman RB, Ahmann FR, Elvick A, Ahmann M, Coults K, and Brawer M: Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. Clin Chem 33: 2086-2088, 1987.
13. Maatman TJ: The role of prostate specific antigen in men with advanced adenocarcinoma of the prostate. J Urol 141: 1378-1380, 1989.
14. Panteghini M, Pagani F, and Bonora R: Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology. Eur J Clin Chem Clin Biochem 30: 135-139, 1992.
15. Yuan JJ, Coplen DE, Petros JA, Figenshau RS, Ratliff TL, Smith DS, and Catalona WJ: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J Urol 147: 810-814, 1992.
16. Franklin J, Marks LS, Dorey F, Shery ED, deKernion JB, Rhodes TR, Partin AW, and Rittenhouse H: Serum PSA levels following TURP in men with BPH: long term characterization. J Urol 155: 378A, 1996.
17. Collins GN, Napier-Henry R, Martin PJ, Brookman PJ, and O'Reilly PH: Characteristics of free PSA activity in clinical urological practice. J Urol 155: 421A, 1996.
18. Hershman JD, Smith DS, and Catalona WJ: Effects of ejaculation on free PSA and total PSA levels. J Urol 155: 423A, 1996.
19. Campo R, Tchetgen M-B, and Oesterling JE: The effects of a short course of antibiotics on the serum PSA concentration. J Urol 155: 425A, 1996.
20. Stenman U-H, Alfthan H, and the Scandinavian BPH Study Group: Effects of long term treatment with finasteride on free and total PSA in serum. J Urol 155: 698A, 1996.
21. Simm B, and Gleeson M: Storage conditions for serum for estimating prostate-specific antigen. Clin Chem 37: 133-114, 1991.
22. Liedtke RJ, and Batjer JD: Measurement of prostate-specific antigen by radioimmunoassay. Clin Chem 30: 649-652, 1984.
23. Leinonen J, Lovgren T, Vornanen T, and Stenman UH: Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin. Clin Chem 39: 2098-2103, 1993.
24. Pettersson K, Piironen T, Seppala M, Liuuonen L, Christenssin A, Matikainen M-T, Suonpaa M, Lovren T, and Lilja H: Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. Clin Chem 41: 1480-1488, 1995.
25. Chen Z, Prestigiacomo A, and Stamey TA: Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays. Clin Chem 41: 1273-1282, 1995.
26. Leinonen J, Zhang W-M, and Stenman U-H: Complex formation between PSA iosenzymes and protease inhibitors. J Urol 155: 1099-1103, 1996.
27. Pearson JD, Partin AW, Chan DW, Luderer AA, and Carter HB: Serial Measurements of serum total PSA, free PSA, and free/total PSA ratio in men with and without prostate disease. J Urol 155: 606A, 1996.
28. Stenman U-H, Hakama M, Knekt P, Aromaa A, Teppo L, and Leinonen J: Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet 344: 1594-1598, 1994.